Kirindo

What Kirindo does

Kirindo Holdings Co., Ltd. (株式会社キリン堂ホールディングス) is a privately held Japanese holding company that, through its core subsidiary 株式会社キリン堂, operates a regional super drugstore, pharmacy, and dispensing pharmacy chain of approximately 300-336 group stores concentrated in the Kansai region (Osaka, Kyoto, Hyogo). The group sells pharmaceuticals, OTC medications, health foods, cosmetics, baby/child care products, and miscellaneous daily goods, with complementary operations in health food manufacturing (株式会社健美舎 / Kenbishya), in-house cleaning and logistics (Kirindo Best Clean Service), and minority interests in China-based e-commerce (View Net Corporation). Its go-to-market is direct-to-consumer through physical retail storefronts, supplemented by an e-commerce site, the KiRiCa proprietary electronic-money/point-card system (deployed across ~330 stores and integrated with the government's マイナポイント program), and the Kirindo Official App (launched October 2019) that uses the unerry beacon SDK for location-based marketing.

The company's value proposition centers on the founder-era 'pre-disease prevention' (未病対策) concept introduced in 1955, positioning Kirindo as community health infrastructure rather than pure retail. Differentiated service offerings include in-store simple blood testing, pharmacist-led health seminars (co-hosted with Nomura Securities and Resona Bank), electronic prescriptions and medication records, dispensing pharmacy services, and the Kirezu private-brand cosmetics line launched in November 2019. Technology stack includes a refreshed automatic ordering system via Synapse (July 2020), new POS systems (March 2018), 11 QR-code payment integrations, and digital health/audit tooling, while distribution is anchored on the Kansai retail footprint with stated ambitions to expand from 300 to 500 stores. The company was publicly traded on the Tokyo Stock Exchange (ticker 3194) from 2000 until a January 2021 MBO led by BCJ-48, after which it was delisted and absorbed into the new Kirindo Holdings in May 2021.

Revenue is generated through transaction-based retail sales (pharmaceuticals, health foods, cosmetics, baby products, daily goods), prescription dispensing fees, and one-time license-style revenue from health food manufacturing/sales via Kenbishya. Pricing is store-based and not publicly disclosed. The primary customer segments are health-conscious general consumers and patients/elderly requiring prescription dispensing services; the customer base is fragmented across millions of in-store transactions, implying low concentration risk but high sensitivity to regional demographic trends, foot traffic, and Japanese pharmacy reimbursement policy.

Name

Kirindo

Legal name

株式会社キリン堂ホールディングス

Website

https://kirindo-hd.co.jp

Company type

Private

Founded year

1958

Operating status

Operating

Headcount range

1–10 employees

Short description

Kirindo Holdings operates approximately 300-336 super drugstore, pharmacy, and dispensing pharmacy stores in Japan's Kansai region, selling pharmaceuticals, health foods, cosmetics, and daily goods to health-conscious consumers and patients. The company went private via MBO in January 2021 and is owned by BCJ-48.

Ownership category

akta.pro rank

Product category

Drugstore Retail

NAICS

Pharmacies and Drug Retailers (45611), Pharmacies and Drug Retailers (456110)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Discount Drugstores (Value-Focused Chain Pharmacies) (CRAEAHAA)

Keywords

• Drugstore retail
• Pharmacy services
• Prescription dispensing
• Health products
• Preventive healthcare

Headquarters

HQ city

Osaka

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Retail Sales: Revenue from selling pharmaceuticals, health foods, cosmetics, baby products, and daily goods through company-owned drugstore chains and pharmacy locations.
2. Pharmacy/Dispensing Services: Revenue from prescription drug dispensing services through pharmacy chain operations.
3. Health Food Manufacturing and Sales: Revenue from 健康食品 (health food) manufacturing and sales through subsidiary株式会社健美舎.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Kirindo Holdings operates a super drugstore chain through its core subsidiary 株式会社キリン堂, selling pharmaceuticals, health foods, cosmetics, baby products, and daily goods across approximately 330 group stores in Japan's Kansai region. The company also runs dispensing pharmacy chains offering prescription drug services and pharmacist consultations, complemented by the proprietary KiRiCa electronic money and point card system and the official mobile app.

Product overview

Kirindo Holdings operates a super drugstore chain business through its group companies, primarily via株式会社キリン堂 (Kirindo Co., Ltd.) which manages super drugstore, pharmacy, and dispensing pharmacy chains selling pharmaceuticals, health foods, cosmetics, baby products, and daily goods. The group is structured as a pure holding company overseeing subsidiaries including株式会社健美舎 (health food and cosmetic manufacturing),キリンドウベストクリーンサービス株式会社 (cleaning services, special subsidiary), and株式会社ビューネットコーポレーション (China IT/e-commerce operations). The consumer-facing retail operations are centered on the Kirindo drugstore brand. Key digital products include the proprietary KiRiCa point card with electronic money functionality and the official mobile app launched in 2019, which delivers personalized customer engagement through notifications, coupons, and location-based services. The group also maintains a private brand cosmetics line including the Kitchizu (キッチズ) brand.

Differentiator

Problem solved

Functional benefit

Products and services

• Kirindo Drugstore Chain (キリン堂) Super drugstore chain, pharmacy chain, and dispensing pharmacy chain operating stores that sell pharmaceuticals, health foods, cosmetics, baby products, and daily goods across approximately 330 group stores primarily in Japan's Kansai region. Serves health-conscious consumers and patients requiring prescription medications.
• Prescription Dispensing Pharmacy Services Prescription drug dispensing services through pharmacy chain locations integrated with drugstore operations, including pharmacist consultations, electronic prescriptions, and medication management for patients and elderly customers.
• KiRiCa (キリカ) Electronic Money and Point Card Proprietary electronic money-embedded point card system deployed across Kirindo Group stores, combining point accumulation, electronic payment (pre-loaded money), and government マイナポイント program eligibility for integrated in-store payments and loyalty rewards.
• Kirindo Official App (キリン堂公式アプリ) Official mobile application providing new arrival notifications, coupon delivery, store search, and push notifications with personalized customer engagement through location and beacon-based data collection.
• Kirezu (キッチズ) Private Brand Cosmetics Private brand cosmetics line featuring 'キッチズ アインシア' as the first Japanese drugstore product to contain Swiftlet Nest Fermentation Extract (アナツバメ巣発酵液).
• In-Store Simple Blood Test Service (店内簡易血液検査サービス) In-store simple blood test service introduced at approximately 330 Kirindo Group stores, enabling customers to receive basic blood screening at the pharmacy as part of the preventive health offering.
• Vegimeter (ベジメーター) Vegetable Intake Meter In-store device measuring vegetable intake status, first deployed in Japan at Kirindo Higashibashi store to support preventive health awareness and customer engagement.

Quantifiable outcome

• Sustainability targets: GHG emissions 12.6% reduction by Feb 2027, 42% reduction by Feb 2034 (per store, vs FY2024)
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Synapse (株式会社シノプシス)coreTechnology or Integration · 9 July 2020Refreshed automatic ordering system across all stores using Synapse system for significant operational efficiency improvement.
• Osaka Prefecture Government (大阪府)minorStrategic or Co-development Partner · 1 August 2019Comprehensive partnership agreement signed, first drugstore chain in Japan to enter such agreement with Osaka Prefecture for community health initiatives.
• Japan GatewayminorGTM or Marketing Partner · 2 July 2018Acquired exclusive sales rights for China e-commerce, restarting for China's Single Day shopping event.
• Inagora (インアゴーラ)minorGTM or Marketing Partner · 28 August 2017Partnership to sell products through Chinese shopping app 'Wandou Princess (豌豆公主)' targeting Chinese users.
• 湖南養天和大薬房企業集団有限公司 (Hunan Yutianhe Drugstore Group)minorStrategic or Co-development Partner · 15 September 2015Business cooperation basic agreement signed for China market operations. 湖南養天和 is a major Chinese pharmacy chain operator.
• BEAUNET CORPORATION LIMITED / View Net Holdings / View Net CorporationminorOthersEquity method affiliate handling China operations including IT mobile beauty portal site operations, e-commerce support, and retail/wholesale operations in China. Restructured in 2020 with company name change to View Net Corporation.
• Nomura Securities (野村證券)minorGTM or Marketing PartnerCo-hosting health seminars (野村のハッピーライフセミナー) where Kirindo pharmacists provide health education and self-medication guidance to participants.
• Resona Bank (りそな銀行)minorGTM or Marketing PartnerCo-hosted health seminar '未病のおはなし' at Resona Bank's Seven Days Plaza Umeda location.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Others

• Alfresa Holdings: Major pharmaceutical wholesaler with distribution to drugstores, dispensing pharmacies, and hospitals in Japan; comparable supply-chain role to Kirindo's pharmacy and OTC drug retail operations.
• Medipal Holdings: Japan's largest pharmaceutical wholesaler supplying drugstores, pharmacies, and hospitals; comparable as upstream supplier to Kirindo's drugstore and dispensing pharmacy operations.
• Suzuken: Pharmaceutical wholesaler and healthcare services group in Japan; comparable to Kirindo as upstream counterpart and adjacent player in the Japanese pharmacy/drugstore value chain.

Broad incumbents

• Welcia Holdings: Japan's largest drugstore chain with ~2,800+ stores including dispensing pharmacies, operating a H&BC retail + pharmacy model directly comparable to Kirindo but at national scale and owned by AEON group.
• Tsuruha Holdings: Major Japanese drugstore chain with national footprint and integrated dispensing pharmacies; one of Kirindo's largest competitive peers in Kansai and beyond, with overlapping OTC, H&BC, and prescription dispensing business.
• Matsukiyo Cocokara & Co. Drugstore and pharmacy chain formed from merger of Matsumoto Kiyoshi and Cocokara Fine; national footprint with strong cosmetics/health positioning, comparable to Kirindo on retail mix but at much larger scale.

Direct peers

• Create SD: Drugstore chain with ~700+ stores concentrated in Hokuriku/Kansai region; comparable mid-scale regional peer with similar drugstore + pharmacy mix and overlapping Kansai geography.
• Sugi Holdings: Drugstore chain with strong dispensing pharmacy focus and ~1,500+ stores including Kansai overlap; directly comparable to Kirindo's drugstore + dispensing pharmacy dual model.
• Sundrug: Drugstore chain operating ~1,300+ stores across Japan with discount-value positioning; directly comparable to Kirindo in store format, OTC/H&BC mix, and prescription dispensing integration.
• Cosmos Pharmaceutical: Discount-focused drugstore chain with ~1,400+ stores in western/southern Japan including Kansai; closely comparable to Kirindo on price-positioning, H&BC/OTC mix, and regional overlap in the Kansai market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/kirindo-holdings-co-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kirindo